Cerebral cavernous malformation

Cerebral cavernous malformation


Neurosurgery Service, Alicante University General Hospital, Alicante, Spain.

There is a grave need for the identification of molecular targets for therapeutic treatment and biomarkers as risk predictors for hemorrhagic stroke prevention. Based on reported various perturbed angiogenic signaling cascades mediated by the CCM signaling complex (CSC), there have been many proposed candidate drugs, targeting potentially angiogenic-relevant signaling pathways dysregulated by loss of function of one of the CCM proteins, which might not be enough to correct the pathological phenotype, hemorrhagic CCMs 2)

Cavernomas comprise 8%-15% of intracranial vascular lesions, usually supratentorial in location and superficial.

Of 164 cerebral cavernous hemangiomas may be found in every age group including the neonatal period. The sex incidence is equal. In 126 cases (76.8%) the cavernomas were of supratentorial, in 34 cases (20.7%) of infratentorial site, and in 4 more cases (2.5%) there was multiple occurence of supratentorial and posterior fossa cavernous haemangiomas 3).

see Cerebral cavernous malformation of the occipital lobe.

25% of them occur in the pediatric age group 4).

see also Pediatric Cavernous Malformation.

There are two forms: familial and sporadic.

see Familial cerebral cavernous malformation.

Sporadic CCMs occur in people with no family history of the disorder. These individuals tend to have only one CCM. Those with sporadic CCM do not have a greater chance of having a child with a CCM than anyone else in the general population.

see Insular Cavernous Malformation

see Frontal lobe cavernous malformation.

see Temporal lobe cavernous malformation.

Cerebral cavernous malformations (CMs) are a source of neurological morbidity from seizures and focal neurological deficits due to mass effect and hemorrhage.

Tuleasca et al. present the pre-, per-, and postoperative course of an inferior parietal cavernous malformation, located in eloquent area, in a 27-year-old right-handed Caucasian male, presenting with intralesional hemorrhage and epilepsy. Preoperative diffusion tensor imaging has shown the cavernous malformation at the interface between the arcuate fasciculus and the inferior fronto-occipital fasciculus. They describe the microsurgical approach, combining preoperative diffusion tensor imagingneuronavigation, awake microsurgical resection, and intraoperative magnetic resonance imaging.

Complete microsurgical en bloc resection has been performed and is feasible even in eloquent locations. Intraoperative magnetic resonance imaging was considered an important adjunct, particularly used in this case as the patient moved during the “awake” phase of the surgery and thus neuronavigation was not accurate anymore. Postoperative course was marked by a unique, generalized seizure without any adverse event. Immediate and 3 months postoperative magnetic resonance imaging confirmed the absence of any residue. Pre- and postoperative neuropsychological exams were unremarkable 5)

A patient who underwent subtotal resection of posterior fossa medulloblastoma with subsequent chemotherapy and radiotherapy at the age of 10 years. A new lesion in the region of the left foramen of Monro appeared 16 years later. Based on the imaging results, metastases or radiation-induced cavernoma was considered. The lesion had the same appearance on imaging as a rarely published intraventricular cavernoma of the foramen of Monro. Unlike the cavernoma of the foramen of Monro, this lesion was subependymal and intraforniceal. Using electromagnetic navigation and neuroendoscopy, the lesion was completely removed. Histopathological examination revealed a cavernous haemangioma.

This is a unique case of intraforniceal paraforaminal cavernoma that was successfully removed endoscopically using electromagnetic neuronavigation and without neurological sequelae. 6).

1) , 2)

Zhang J, Abou-Fadel JS. Calm the raging hormone – A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs. Vessel Plus. 2021;5:48. Epub 2021 Jul 5. PMID: 35098046; PMCID: PMC8796995.

Voigt K, Yaşargil MG. Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg). 1976 Mar;19(2):59-68. PubMed PMID: 1264322.

Kosnik-Infinger L, Carroll C, Greiner H, Leach J, Mangano FT. Management of cerebral cavernous malformations in the pediatric population: a literature review and case illustrations. J Neurosurg Sci. 2015 Sep;59(3):283-94. Epub 2015 May 22. Review. PubMed PMID: 25998208.

Tuleasca C, Peciu-Florianu I, Strachowski O, Derre B, Vannod-Michel Q, Reyns N. How to combine the use of intraoperative magnetic resonance imaging (MRI) and awake craniotomy for microsurgical resection of hemorrhagic cavernous malformation in eloquent area: a case report. J Med Case Rep. 2023 Apr 12;17(1):160. doi: 10.1186/s13256-023-03816-1. PMID: 37041613.

Liby P, Zamecnik J, Kyncl M, Zackova J, Tichy M. Electromagnetic navigation-guided neuroendoscopic removal of radiation-induced intraforniceal cavernoma as a late complication of medulloblastoma treatment. Childs Nerv Syst. 2017 Jul 8. doi: 10.1007/s00381-017-3519-6. [Epub ahead of print] PubMed PMID: 28689346.

Leave a Reply